Light-it Group Launches Enlighten Ventures: A Micro-VC Initiative to Propel Healthtech Innovation

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Javier Lempert (CTO & Founder), Alan Brande (CEO & Founder) and Martin Oppenheimer (COO & Founder) at Light-it’s HQ.

AVENTURA, Fla., Dec. 20, 2024 (GLOBE NEWSWIRE) — Light-it Group, a leading innovator in digital health solutions, proudly announces the launch of Enlighten Ventures, a micro-VC initiative dedicated to investing in early-stage digital health startups. This new venture underscores Light-it’s commitment to advancing innovation and supporting the growth of the healthtech ecosystem.

Introducing Enlighten Ventures

Enlighten Ventures, the group’s latest initiative, is a micro-VC focused on investing in innovative seed and pre-seed healthtech startups disrupting the industry. By targeting startups developing digital health tools and AI and Generative AI-driven healthcare solutions, Enlighten Ventures aims to accelerate healthcare transformation while bringing impactful solutions to life.

“With Enlighten Ventures, we’re extending our mission beyond building exceptional digital health products. We’re empowering early-stage startups to grow and tackle some of healthcare’s most pressing challenges,” said Alan Brande, President of Light-it Group. “Our expertise and network provide a unique value proposition to startups aiming to innovate in this complex, high-impact space.”

Investment Focus

Enlighten Ventures seeks to invest in startups at the forefront of digital health innovation. This includes companies developing cutting-edge digital health tools, AI-driven solutions, and digital health products and platforms that enhance patient care, streamline healthcare processes, and reduce clinical burden.

Support Beyond Capital

Light-it Group is committed to providing more than just financial support, it also aims to nurture startups with the tools they need to scale effectively. Startups backed by Light-it’s VC will benefit from strategic guidance, product development expertise, and access to a network of industry experts.

Commitment to Innovation

Light-it has a long-standing reputation for excellence in healthtech innovation. Launching Enlighten Ventures reinforces its dedication to nurturing startups that address real-world healthcare challenges.

Call to Action for Founders

Healthtech startup founders are encouraged to apply for funding and partnership opportunities through Enlighten Ventures. This is a unique chance to collaborate with a leader in digital health innovation and gain the support needed to bring groundbreaking solutions to the market.

About Light-it Group

Light-it is a premier software development company and consultancy agency specializing in healthtech and digital health product innovation. Light-it is at the forefront of healthcare technology and has a track record of working with industry leaders such as Oxford University, Best Buy, and AB InBev Foundation.

Other Companies owned by the Group

  • DHI (Digital Health Insider): A leading digital press medium and community curating top news and trends, organizing thought leadership events, and creating custom content for the industry.
  • Puppeteer: An AI platform enabling healthcare companies to leverage patient-facing generative AI in a powerful, compliant, and safe manner.
  • CompliantChatGPT: An AI medical copilot that optimizes workflows, allowing healthcare professionals to spend more time with patients.

There is Much More to Know

Contact us if you want to learn about Light-it and its collaboration with world-class healthcare organizations and companies through the launch of leading-edge digital products and passion for innovation.

For media inquiries, please contact:

Alan Brande, Founder & CEO at Light-it
press@lightit.io
lightit.io

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f1d606ac-0002-4d16-ba80-4c6ae4e1fbd2

Staff

Recent Posts

Assembly Biosciences Presents Data Highlighting Recurrent Genital Herpes Program at STI & HIV 2025 World Congress and International Herpesvirus Workshop

– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…

13 hours ago

ISS Recommends Shareholders Vote FOR the Merger between Regional Health Properties, Inc. and SunLink Health Systems, Inc.

Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…

13 hours ago

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

13 hours ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…

13 hours ago

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…

13 hours ago

IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025

ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…

13 hours ago